Westchester Capital Management (New York)’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-593,690
Closed -$5.96M 404
2022
Q4
$5.96M Buy
593,690
+112,782
+23% +$1.12M 0.16% 139
2022
Q3
$4.72M Buy
480,908
+8,000
+2% +$78.6K 0.13% 151
2022
Q2
$4.63M Buy
472,908
+279,813
+145% +$2.74M 0.13% 154
2022
Q1
$1.89M Buy
+193,095
New +$1.88M 0.05% 242

Other funds holding AONC

Westchester Capital Management (New York)'s AONC Position: Q1 2023 in Review

Westchester Capital Management (New York) sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 593,690 shares — an estimated $5.96M sold.

Westchester Capital Management (New York) first reported a position in AONC in Q1 2022 and held it in 4 quarters. The position peaked at $5.96M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Westchester Capital Management (New York) reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 593,690 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $5.96M.
  • Westchester Capital Management (New York) first reported a position in American Oncology Network, Inc. Class A Common Stock in Q1 2022 and held it in 4 quarters.
  • Westchester Capital Management (New York)'s American Oncology Network, Inc. Class A Common Stock position peaked at $5.96M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2023, filed 15 May 2023.